{"id":1067939,"date":"2020-10-21T11:35:27","date_gmt":"2020-10-21T15:35:27","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/zosano-pharma-receives-complete-response-letter-from-fda-for-qtrypta\/"},"modified":"2024-08-18T11:41:08","modified_gmt":"2024-08-18T15:41:08","slug":"zosano-pharma-receives-complete-response-letter-from-fda-for-qtrypta","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/zosano-pharma-receives-complete-response-letter-from-fda-for-qtrypta.php","title":{"rendered":"Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta\u2122"},"content":{"rendered":"<p><![CDATA[--FDA feedback consistent with FDA\u2019s preliminary communication in September----Company requesting meeting with FDA to discuss next steps required to resubmit the NDA--FREMONT, Calif., Oct.  21, 2020  (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, announced today that it has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) in connection with the Qtrypta\u2122 (zolmitriptan transdermal microneedle system) 505(b)(2) New Drug Application (NDA).]]><\/p>\n<p>See the rest here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/10\/21\/2111872\/0\/en\/Zosano-Pharma-Receives-Complete-Response-Letter-from-FDA-for-Qtrypta.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta\u2122\">Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta\u2122<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the rest here: Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta\u2122 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/zosano-pharma-receives-complete-response-letter-from-fda-for-qtrypta.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1067939","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067939"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1067939"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067939\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1067939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1067939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1067939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}